✦ LIBER ✦

Randomised phase 3 open-label trial of first-line treatment with gemcitabine in association with docetaxel or paclitaxel in women with metastatic breast cancer: a comparison of different schedules and treatments

✍ Scribed by Lucia Del Mastro, Alessandra Fabi, Mauro Mansutti, Michele De Laurentiis…

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A Phase II Trial of Gemcitabine/Carbopla

✍ Denise A. Yardley; Howard A. Burris III; Lisa Simons; David R. Spigel; F. Anthon 📂 Article 📅 2008 🏛 CIG Media Group, LP. 🌐 English ⚖ 117 KB

Phase II Trial of Weekly Docetaxel/Gemci

✍ Joyce A. O'Shaughnessy; Robert Pluenneke; Jack Sternberg; Pankaj Khandelwal; Des 📂 Article 📅 2006 🏛 CIG Media Group, LP. 🌐 English ⚖ 482 KB

Phase II Multicenter Trial of Albumin-Bo

✍ Lee S. Schwartzberg; Francis P. Arena; David M. Mintzer; Amanda L. Epperson; Mar 📂 Article 📅 2012 🏛 CIG Media Group, LP. 🌐 English ⚖ 391 KB

Docetaxel/gemcitabine or cisplatin/gemci

✍ D. Binder; H. Schweisfurth; C. Grah; C. Schäper; B. Temmesfeld-Wollbrück; G. Sie 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 340 KB

Motesanib, or open-label bevacizumab, in

✍ Miguel Martin; Henri Roche; Tamas Pinter; John Crown; M John Kennedy; Louise Pro 📂 Article 📅 2011 🏛 The Lancet 🌐 English ⚖ 230 KB

P-457 Docetaxel/gemcitabine vs. cisplati

✍ Binder, D.; Schweisfurth, H.; Grah, C.; Schäper, C.; Temmesfeld-Wollbrück, B.; S 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 276 KB